Filter Results:
(446)
Show Results For
- All HBS Web
(632)
- People (2)
- News (55)
- Research (446)
- Events (2)
- Multimedia (8)
- Faculty Publications (391)
Show Results For
- All HBS Web
(632)
- People (2)
- News (55)
- Research (446)
- Events (2)
- Multimedia (8)
- Faculty Publications (391)
Sort by
- January 2010 (Revised August 2011)
- Case
Ganeden Biotech, Inc.
By: Robert C. Pozen, Dale Alan Winger and Matthew Kenneth Ahlers
The CEO of Ganeden Biotech, a small firm with several viable probiotic products but limited resources, must decide what markets to invest in and what intellectual property strategies will best serve its immediate and longer-term business interests. View Details
Keywords: Entrepreneurship; Investment; Intellectual Property; Market Entry and Exit; Business Strategy; Biotechnology Industry
Pozen, Robert C., Dale Alan Winger, and Matthew Kenneth Ahlers. "Ganeden Biotech, Inc." Harvard Business School Case 310-073, January 2010. (Revised August 2011.)
- November 2009 (Revised March 2010)
- Case
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon
In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details
Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Marketing Strategy; Product Positioning; Genetics; Biotechnology Industry; Europe; United States
Hamermesh, Richard G., Raju Kucherlapati, and Rachel Gordon. "Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story." Harvard Business School Case 810-066, November 2009. (Revised March 2010.)
- July 2009
- Teaching Note
Targanta Therapeutics: Hitting a Moving Target (TN)
By: Arthur A. Daemmrich
Teaching Note for [709002]. View Details
- May 2004
- Teaching Note
Monsanto: Technology Cooperation and Small Holder Farmer Projects (TN)
By: James E. Austin and Diana Barrett
Teaching Note to (9-302-068). View Details
Keywords: Biotechnology Industry
- November 2001 (Revised December 2002)
- Case
Tracking Stocks at Genzyme (A)
Genzyme, a tracking stock pioneer, has used its innovative capital structure as a way to frame and grow its R&D-intensive business. Facing the question of how best to integrate a new acquisition into its tracking stock structure, Genzyme's top management is forced to... View Details
Keywords: Integration; Value Creation; Motivation and Incentives; Conflict of Interests; Stocks; Capital Structure; Research and Development; Corporate Governance; Biotechnology Industry
Salter, Malcolm S. "Tracking Stocks at Genzyme (A)." Harvard Business School Case 902-023, November 2001. (Revised December 2002.)
- October 2001
- Case
TIGR and ILRI: Solving Problems with Genomics
By: Ray A. Goldberg and James M Beagle
Discusses nonprofit institutional leadership applying advances in genetic science to solve health and animal problems in industrial countries and the developing world. View Details
- October 2001 (Revised June 2002)
- Case
Centagenetix (A): Building a Business Model for Genetic Longevity
Describes a start-up company seeking to exploit population genetic data from long-lived, healthy people. The company must address legal, financial, ethical, and personal issues among its team to launch the company. View Details
Chesbrough, Henry W., and Frank Angella. "Centagenetix (A): Building a Business Model for Genetic Longevity." Harvard Business School Case 602-087, October 2001. (Revised June 2002.)
- April 2001 (Revised January 2003)
- Case
Robert Shapiro and Monsanto
Traces Monsanto's efforts to become a global biotech powerhouse under Shapiro's leadership. Examines how his crusade to save the world through genetic modification foundered. View Details
Keywords: Genetics; Supply Chain Management; Alliances; Global Strategy; Cross-Cultural and Cross-Border Issues; Biotechnology Industry
Watkins, Michael D., and Ann Leamon. "Robert Shapiro and Monsanto." Harvard Business School Case 801-426, April 2001. (Revised January 2003.)
- December 2000
- Case
Paradigm Genetics: The Industrialization of Genomics
By: Ray A. Goldberg, Carin-Isabel Knoop and Laure Mougeot Stroock
Goldberg, Ray A., Carin-Isabel Knoop, and Laure Mougeot Stroock. "Paradigm Genetics: The Industrialization of Genomics." Harvard Business School Case 901-011, December 2000.
- November 1999
- Case
Seminis Inc.
By: Ray A. Goldberg, Jonathan West, Carin-Isabel Knoop and David Benedict Pearcy
Seminis became the world leader in vegetable seeds through a series of acquisitions. This case describes the Seminis strategy toward capturing value, biotechnology, and international operations. View Details
Keywords: Business Earnings; Acquisition; Profit; Global Strategy; Corporate Strategy; Valuation; Value Creation; Biotechnology Industry
Goldberg, Ray A., Jonathan West, Carin-Isabel Knoop, and David Benedict Pearcy. "Seminis Inc." Harvard Business School Case 600-030, November 1999.
- August 1996 (Revised May 1997)
- Case
Delta & Pine Land: Measuring the Value of Transgenic Cotton
By: Ray A. Goldberg and Charlotte A. Tasker
Discusses the joint venture between two companies with different capabilities: 1) technology provider and 2) transportation agent. Discusses how to capture value from joint venture and biotechnology: 1) who are winners and who are losers; 2) how much value can/should... View Details
Keywords: Agribusiness; Joint Ventures; Marketing Strategy; Supply Chain Management; Performance Consistency; Information Technology; Transportation; Valuation; Biotechnology Industry
Goldberg, Ray A., and Charlotte A. Tasker. "Delta & Pine Land: Measuring the Value of Transgenic Cotton." Harvard Business School Case 597-005, August 1996. (Revised May 1997.)
- November 1995 (Revised February 1996)
- Case
Monsanto Company: The Coming of Age of Bio-Technology
By: Ray A. Goldberg and Thomas N. Urban Jr
Monsanto has one product, Roundup, accounting for 30% of company net income and is going off patent. How should the company position itself and its products in the future? View Details
Goldberg, Ray A., and Thomas N. Urban Jr. "Monsanto Company: The Coming of Age of Bio-Technology." Harvard Business School Case 596-034, November 1995. (Revised February 1996.)
- November 1978 (Revised October 1989)
- Case
Amicon Corp. (B)
Details the negotiation between Amicon and three potential licensees, Jackson, Maynard-Smith and Behrstein. View Details
Keywords: Technology; Patents; Negotiation Process; Negotiation Participants; Health Care and Treatment; Biotechnology Industry
Capon, Noel. "Amicon Corp. (B)." Harvard Business School Case 579-094, November 1978. (Revised October 1989.)
- October 2020 (Revised April 2022)
- Case
When Institutions Fail: HIV/AIDS in the 1980s
By: Tom Nicholas and Christian Godwin
During the early 1980s, young gay men in urban centers such as San Francisco and New York City began contracting a mysterious illness that would come to be known as HIV/AIDS. A diagnosis meant almost certain death, with a less than 1% survival rate. Conflicting... View Details
Keywords: Ethics; Policy; Government and Politics; Health Pandemics; History; Rights; Media; Organizations; Business and Community Relations; Religion; Social Psychology; Identity; Prejudice and Bias; Social Issues; Public Opinion; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States
Nicholas, Tom, and Christian Godwin. "When Institutions Fail: HIV/AIDS in the 1980s." Harvard Business School Case 821-002, October 2020. (Revised April 2022.)
- January 2016 (Revised February 2016)
- Course Overview Note
The Sustainable Core: Operations Management
By: Michael W. Toffel and L. Beril Toktay
This note is designed to help faculty embed environmental sustainability content into their core Operations Management course at the MBA or undergraduate level. It can also be used to identify cases with environmental content that can be used in operations electives... View Details
Keywords: Environmental Management; Operations Management; Sustainable Operations; Environmental Regulation; Operations; Supply Chain; Supply Chain Management; Agriculture and Agribusiness Industry; Biotechnology Industry; Food and Beverage Industry; Construction Industry; Forest Products Industry; Retail Industry
Toffel, Michael W., and L. Beril Toktay. "The Sustainable Core: Operations Management." Harvard Business School Course Overview Note 616-022, January 2016. (Revised February 2016.)
- 03 Sep 2013
- First Look
First Look: September 3
results. Purchase this case: http://hbr.org/search/713537-PDF-ENG Harvard Business School Case 814-014 Sample6: Innovating to Make Food Safer Tim Curran, CEO of Sample6, a start-up biotechnology company developing a novel food safety... View Details
Keywords: Sean Silverthorne
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
is a lot other work at the school going on around these issues by many other faculty. For instance, Dave Scharfstein is doing great work on how capital market forces influence the development strategies of biotechnology companies. David... View Details
- 19 May 2009
- First Look
First Look: May 19, 2009
the significance levels are lower. Cases & Course MaterialsAdnexus Therapeutics, Inc.: Considering the Exit Harvard Business School Case 609-015 Dr. John Mendlein, CEO of Adnexus Therapeutics Inc. (Adnexus), a private biotechnology... View Details
Keywords: Martha Lagace
- 12 May 2009
- First Look
First Look: May 12, 2009
Case 809-026 An executive from pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's global head of R&D, championed the acquisition of Sirtris to gain access... View Details
Keywords: Martha Lagace
- 06 Feb 2007
- First Look
First Look: February 6, 2007
India, and asks if the world's leading biotechnology firm should develop similar delivery-based systems. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=507018 RKS Guitars Harvard Business School Case... View Details
Keywords: Martha Lagace